Giovanni Taccetti

4.8k total citations · 1 hit paper
113 papers, 2.3k citations indexed

About

Giovanni Taccetti is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Giovanni Taccetti has authored 113 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Giovanni Taccetti's work include Cystic Fibrosis Research Advances (85 papers), Tracheal and airway disorders (33 papers) and Neonatal Respiratory Health Research (33 papers). Giovanni Taccetti is often cited by papers focused on Cystic Fibrosis Research Advances (85 papers), Tracheal and airway disorders (33 papers) and Neonatal Respiratory Health Research (33 papers). Giovanni Taccetti collaborates with scholars based in Italy, United Kingdom and Germany. Giovanni Taccetti's co-authors include Silvia Campana, Filippo Festini, S. Campana, Gerd Döring, Vito Terlizzi, Massimiliano Mascherini, Félix Ratjen, Lisa Cariani, Patrick A. Flume and Scott C. Bell and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and European Respiratory Journal.

In The Last Decade

Giovanni Taccetti

106 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines

2014 371 citations Alan R Smyth, Scott C. Bell et al. Journal of Cystic Fibrosis profile →

Peers

Countries citing papers authored by Giovanni Taccetti

Since Specialization

Citations

This map shows the geographic impact of Giovanni Taccetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Taccetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Taccetti more than expected).

Fields of papers citing papers by Giovanni Taccetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Taccetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Taccetti. The network helps show where Giovanni Taccetti may publish in the future.

Co-authorship network of co-authors of Giovanni Taccetti

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Taccetti. A scholar is included among the top collaborators of Giovanni Taccetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Taccetti. Giovanni Taccetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers 2025 ·Journal of Cystic Fibrosis ·Jessica Conti, (unknown), (unknown), (unknown), (unknown), Alessia Farinazzo, Luca Rodella, (unknown), Arianna Massella, Luca Frulloni, Giovanni Taccetti, Vito Terlizzi, (unknown), (unknown), Marcel J. C. Bijvelds, Paola Melotti, Claudio Sorio	2
2	Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study 2025 ·Therapeutic Advances in Respiratory Disease ·Angela Pepe, (unknown), Daniela Dolce, Silvia Campana, N. Ravenni, Giovanni Taccetti, Donatello Salvatore, Vito Terlizzi	3
3	Antibiotic treatment of bacterial lung infections in cystic fibrosis 2024 ·European Journal of Pediatrics ·Giovanni Taccetti, Vito Terlizzi, Silvia Campana, Daniela Dolce, N. Ravenni, (unknown), Michela Francalanci, (unknown), Anna Silvia Neri	1
4	CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids 2024 ·Orphanet Journal of Rare Diseases ·(unknown), Paola Melotti, (unknown), (unknown), Giovanni Taccetti, Vito Terlizzi, Claudio Sorio	2
5	Non pathological sweat test, pancreatic insufficiency and Cystic Fibrosis: an unusual case in a child with F508del-duplication of exons 1–3 CFTR genotype 2024 ·BMC Pediatrics ·Vito Terlizzi, (unknown), Alice Castaldo, Simone Vespa, Daniela Dolce, Luca Scarallo, (unknown), Paola Melotti, Claudio Sorio, Giovanni Taccetti, Paolo Lionetti	1
6	Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy 2024 ·BMJ Open Respiratory Research ·Pierre‐Régis Burgel, Manfred Ballmann, Pavel Dřevı́nek, Harry Heijerman, Andreas Jung, Jochen G. Mainz, D. Peckham, Barry J. Plant, C. Schwarz, Giovanni Taccetti, Alan R Smyth	9
7	A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening 2023 ·Children ·Antonella Tosco, (unknown), (unknown), (unknown), Rita Padoan, (unknown), Benedetta Fabrizzi, Giovanni Taccetti, (unknown), Vito Terlizzi	7
8	Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study 2022 ·Journal of Clinical Medicine ·Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, (unknown), (unknown), Angela Pepe, Michela Francalanci, Giovanni Taccetti, (unknown), (unknown), Laura Salvadori, (unknown), (unknown), Nicola Ferrara, Donatello Salvatore	39
9	Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype 2021 ·Antibiotics ·Marika Comegna, Vito Terlizzi, Donatello Salvatore, (unknown), Antonella Miriam Di Lullo, (unknown), Giovanni Taccetti, Giuseppe Castaldo, Felice Amato	21
10	Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype 2021 ·Respiratory Medicine ·Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, (unknown), (unknown), (unknown), Fabiola De Gregorio, Michela Francalanci, Giovanni Taccetti, (unknown), (unknown), (unknown), (unknown), Nicola Ferrara, Donatello Salvatore	38
11	Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease 2021 ·Genes ·Vito Terlizzi, (unknown), (unknown), (unknown), Michela Francalanci, (unknown), (unknown), (unknown), Giovanni Taccetti, Felice Amato, Marika Comegna, Giuseppe Castaldo, Donatello Salvatore	21
12	Unilateral temporary diaphragmatic paralysis secondary to bronchial artery embolization in a girl with cystic fibrosis and massive hemoptysis: a case report 2020 ·BMC Pulmonary Medicine ·Vito Terlizzi, (unknown), (unknown), Fabrizio Fanelli, Marco De Martino, Giovanni Taccetti	0
13	Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices 2019 ·Journal of Cystic Fibrosis ·Edith T. Zemanick, Pierre‐Régis Burgel, Giovanni Taccetti, Alison Holmes, Félix Ratjen, Catherine A. Byrnes, Valerie J. Waters, Scott C. Bell, Donald R. VanDevanter, J.S. Elborn, Patrick A. Flume	22
14	Early antibiotic treatment forPseudomonas aeruginosaeradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols 2012 ·Thorax ·Giovanni Taccetti, Elisa Bianchini, Lisa Cariani, Roberto Buzzetti, Diana Costantini, Francesca Trevisan, (unknown), Silvia Campana	79
15	Bone mineral density in cystic fibrosis patients under the age of 18 years. 2008 ·PubMed ·(unknown), (unknown), Filippo Festini, Laura Masi, Maria Luisa Brandi, (unknown), C. Braggion, Giovanni Taccetti	6
16	Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex 2008 ·FEMS Microbiology Letters ·Silvia Tabacchioni, Lorenzo Ferri, G. Manno, M. Mentasti, P. Cocchi, Silvia Campana, N. Ravenni, Giovanni Taccetti, Claudia Dalmastri, Luigi Chiarini, Annamaria Bevivino, Renato Fani	21
17	Breast-feeding in a woman with cystic fibrosis undergoing antibiotic intravenous treatment 2006 ·The Journal of Maternal-Fetal & Neonatal Medicine ·Filippo Festini, (unknown), Giovanni Taccetti, T. Repetto, Silvia Campana, Maurizio de Martino, (unknown), (unknown), (unknown)	3
18	428 Pain in children and adults with cystic fibrosis: a comparative study 2005 ·Journal of Cystic Fibrosis ·(unknown), Filippo Festini, (unknown), (unknown), N. Ravenni, Giovanni Taccetti, (unknown), (unknown), (unknown)	1
19	Sweat testing in newborns positive to neonatal screening for cystic fibrosis: Table 1 2004 ·Archives of Disease in Childhood Fetal & Neonatal ·Giovanni Taccetti, (unknown), (unknown), (unknown), (unknown)	12
20	Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center 2004 ·Journal of Cystic Fibrosis ·Silvia Campana, Giovanni Taccetti, N. Ravenni, (unknown), (unknown), (unknown), T. Repetto, Gerd Döring, Maurizio de Martino	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact